An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

计划入组 21 人 · 首次发布于 2021 年 10 月 20 日

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

计划入组 33 人 · 首次发布于 2021 年 10 月 28 日

Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis

计划入组 192 人 · 首次发布于 2023 年 10 月 16 日

HTX-001

Centyrin-Targeted Oligonucleotide

RNA-targeted therapeutic (cancer)

Rna Diagnostics, Inc.

Canada

RNA Pharma, LLC

United States

BioNTech RNA Pharmaceuticals GmbH

Germany

Lilly Partners with Creyon Bio in $1B+ Deal to Develop AI-Designed RNA Therapies

AI Is Reshaping RNA-Targeted Drug Discovery, From Small Molecules to Oligonucleotides

Lundbeck Partners with Contera Pharma to Develop RNA-Targeting Oligonucleotide Therapies for Neurological Disorders